GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for ChemoCentryx Stock and on which exchange is it traded?
The symbol for ChemoCentryx is CCXI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ChemoCentryx Stock?
ChemoCentryx holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ChemoCentryx Stock?
ChemoCentryx Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ChemoCentryx Stock.

What's the current price of ChemoCentryx Stock?
As of the end of day on the 2023-01-27, the price of an ChemoCentryx (CCXI) share was $51.99.

What is the 52-week high and low for ChemoCentryx Stock?
The 52-week high for ChemoCentryx Stock is $52.00 and the 52-week low is $14.95.
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT